In this section
@article{Trizzino:2018:10.1016/j.celrep.2018.05.097,
author = {Trizzino, M and Barbieri, E and Petracovici, A and Wu, S and Welsh, SA and Owens, TA and Licciulli, S and Zhang, R and Gardini, A},
doi = {10.1016/j.celrep.2018.05.097},
journal = {Cell Reports},
pages = {3933--3945},
title = {The tumor suppressor ARID1A controls global transcription via pausing of RNA polymerase II},
url = {http://dx.doi.org/10.1016/j.celrep.2018.05.097},
volume = {23},
year = {2018}
}
TY - JOUR
AB - AT-rich interactive domain-containing proteins 1A and 1B (ARID1A and ARID1B) are mutually exclusive subunits of the chromatin remodeler SWI/SNF. ARID1A is the most frequently mutated chromatin regulator across all cancers, and ovarian clear cell carcinoma (OCCC) carries the highest prevalence of ARID1A mutations (∼57%). Despite evidence implicating ARID1A in tumorigenesis, the mechanism remains elusive. Here, we demonstrate that ARID1A binds active regulatory elements in OCCC. Depletion of ARID1A represses RNA polymerase II (RNAPII) transcription but results in modest changes to accessibility. Specifically, pausing of RNAPII is severely impaired after loss of ARID1A. Compromised pausing results in transcriptional dysregulation of active genes, which is compensated by upregulation of ARID1B. However, a subset of ARID1A-dependent genes is not rescued by ARID1B, including many p53 and estrogen receptor (ESR1) targets. Our results provide insight into ARID1A-mediated tumorigenesis and unveil functions of SWI/SNF in modulating RNAPII dynamics.
AU - Trizzino,M
AU - Barbieri,E
AU - Petracovici,A
AU - Wu,S
AU - Welsh,SA
AU - Owens,TA
AU - Licciulli,S
AU - Zhang,R
AU - Gardini,A
DO - 10.1016/j.celrep.2018.05.097
EP - 3945
PY - 2018///
SN - 2211-1247
SP - 3933
TI - The tumor suppressor ARID1A controls global transcription via pausing of RNA polymerase II
T2 - Cell Reports
UR - http://dx.doi.org/10.1016/j.celrep.2018.05.097
VL - 23
ER -
Interested in studying a PhD at the Department of Life Sciences? Find out more about postgraduate research opportunties.